On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Astellas Pharma (United Kingdom)

InstitutionResearch output, impact & collaborations

Astellas Pharma (United Kingdom) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Astellas Pharma (United Kingdom)?

ScholarIQrecord summary

Astellas Pharma (United Kingdom) is a research organisation in London, GB. OpenAlex records 702 works and 81,535 citations for it. 154 researchers list it as their most recent affiliation.

How many works does Astellas Pharma (United Kingdom) have?

ScholarIQindexed works

Astellas Pharma (United Kingdom) has 702 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Astellas Pharma (United Kingdom) have?

ScholarIQcitation count

Astellas Pharma (United Kingdom) has 81,535 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Astellas Pharma (United Kingdom)?

ScholarIQresearcher count

Astellas Pharma (United Kingdom) has 154 researchers in the ScholarIQ index.

What is the average h-index at Astellas Pharma (United Kingdom)?

ScholarIQavg h-index

Astellas Pharma (United Kingdom) has an average h-index of 12 in OpenAlex.

What is the ROR of Astellas Pharma (United Kingdom)?

ScholarIQror

The ROR for Astellas Pharma (United Kingdom) is on the source record.

What is the OpenAlex record for Astellas Pharma (United Kingdom)?

ScholarIQopenalex

The OpenAlex for Astellas Pharma (United Kingdom) is on the source record.

Who are the most-cited researchers behind Astellas Pharma (United Kingdom)?

ScholarIQtop researchers by citations
1
Boyka Stoykova · Health Systems, Economic Evaluations, Quality of Life
29 works1,367 citations

What are the most-cited papers on Astellas Pharma (United Kingdom)?

ScholarIQmost cited works
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
Henry C Kitchener, Maribel Almonte, Claire Thomson, Paula Wheeler, Alexandra Sargent, Boyka Stoykova, Clare Gilham, Hélène Baysson, Christopher Roberts, Robin Dowie, Mina Desai, Jean Mather, Andrew Bailey, Andrew Turner, Sue Moss, Julian Peto
The Lancet Oncology. 2009395 Citations
Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden
Rossella E. Nappi, Robin Kroll, Emad Siddiqui, Boyka Stoykova, Carol Rea, E. Gemmen, Neil M. Schultz
Menopause The Journal of The North American Menopause Society. 2021215 CitationsOPEN ACCESS
ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening
HC Kitchener, Maribel Almonte, Clare Gilham, Robin Dowie, Boyka Stoykova, Alexandra Sargent, Caleb Roberts, M. Desai, Julian Peto
Health Technology Assessment. 2009185 CitationsOPEN ACCESS
Re: Hutton J, Brown R. Use of economic evaluation in decision-making: what needs to change? (Editorial) Value Health 2002;5:65-6.
Chritiane Hoffmann, Boyka Stoykova, John Nixon, Julie Glanville, Kate Misso, Michael Drummond
PubMed. 2002121 Citations
Do Health-Care Decision Makers Find Economic Evaluations Useful? The Findings of Focus Group Research in UK Health Authorities
Christiane Hoffmann, Boyka Stoykova, John Nixon, Julie Glanville, Kate Misso, Michael Drummond
Value in Health. 2002119 CitationsOPEN ACCESS

How much of the research on Astellas Pharma (United Kingdom) is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
20%
Green
10%
Hybrid
0%
Bronze
30%
Closed
40%

Related on ScholarIQ

470M+ articles · 14-day free trial